Subcellular localization of PUMA regulates its pro-apoptotic activity in Burkitt's lymphoma B cells

Abstract

The BH3-only protein PUMA (p53-upregulated modulator of apoptosis) is a major regulator of apoptosis. It belongs to the Bcl-2 family of proteins responsible for maintaining mitochondrial outer membrane integrity by controlling the intrinsic (mitochondrial) apoptotic pathway. We describe here a new pathway regulating PUMA activation through the control of its subcellular distribution. Surprisingly, neither PUMA upregulation in normal activated human B lymphocytes nor high levels of PUMA in Burkitt's lymphoma (BL) were associated with cell death. We show that PUMA is localized to the cytosol in these cells. By contrast, various apoptosis-triggering signals were found to promote the translocation of PUMA to the mitochondria in these cells, leading to their death by apoptosis. This apoptosis was associated with the binding of mitochondrial PUMA to anti-apoptotic members of the Bcl-2 family, such as Bcl-2 and Mcl-1. This translocation was caspase-independent but was prevented by inhibiting or knocking down the expression of the MAPK kinase p38. Our data suggest that the accumulation of PUMA in the cytosol may be important for the participation of this protein in apoptosis without the need for prior transcription. This regulatory pathway may be an important feature of differentiation and tumorigenic processes.

Cis‐Nerolidol Induces Endoplasmic Reticulum Stress and Cell Death in Human Hepatocellular Carcinoma Cells through Extensive CYP2C19 and CYP1A2 Oxidation

“…Puma, a pro-apoptotic protein coded by BBC3, is related to caspase-independent cell death [38,39] and was increased after C-NER treatment after 6 and 12 hr, corroborating the caspaseindependent cell death.…”

MEK inhibitors induce apoptosis via FoxO3a-dependent PUMA induction in colorectal cancer cells

“…PUMA is both a direct p53 target, and can be induced via apoptosis that is independent of p53 in response to a variety of stimulations 12 , 13 . Normally, the localization of PUMA is mainly in the mitochondria in cells 14 . In the apoptotic process, PUMA-mediated mitochondrial dysfunction leads to apoptosis 15 .…”

SHYCD induces APE1/Ref-1 subcellular localization to regulate the p53-apoptosis signaling pathway in the prevention and treatment of acute on chronic liver failure

“…The Bcl-2 family of proteins is associated with caspase activation factors and dimer formation. Activated caspase precursors are synthesized on the mitochondrial membrane pores and act to control the release of the activators in the mitochondria, regulate cell survival, and apoptosis [ 47 ]. Mitochondrial damage occurs when cellular antioxidants are depleted and ROS accumulation reaches a critical threshold.…”